Cencora
0
Funds holding %
of 7,390 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
87% more first-time investments, than exits
New positions opened: 168 | Existing positions closed: 90
30% more call options, than puts
Call options by funds: $1.2B | Put options by funds: $924M
22% more repeat investments, than reductions
Existing positions increased: 472 | Existing positions reduced: 386
5% more funds holding
Funds holding: 1,146 [Q3] → 1,199 (+53) [Q4]
0.48% less ownership
Funds ownership: 100.62% [Q3] → 100.13% (-0.48%) [Q4]
3% less capital invested
Capital invested by funds: $44.6B [Q3] → $43.5B (-$1.12B) [Q4]
20% less funds holding in top 10
Funds holding in top 10: 15 [Q3] → 12 (-3) [Q4]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$251
7%
downside
Avg. target
$277
3%
upside
High target
$301
12%
upside
4 analyst ratings
2 positive
50%
2 neutral
50%
0 negative
0%
Wells Fargo Stephen Baxter 33% 1-year accuracy 13 / 39 met price target | 2%upside $274 | Equal-Weight Maintained | 14 Mar 2025 |
Evercore ISI Group John Belton 75% 1-year accuracy 3 / 4 met price target | 4%upside $280 | Outperform Maintained | 6 Feb 2025 |
Wells Fargo Eric Luebchow 36% 1-year accuracy 16 / 45 met price target | 7%downside $251 | Equal-Weight Maintained | 29 Jan 2025 |
JP Morgan Lisa Gill 70% 1-year accuracy 16 / 23 met price target | 12%upside $301 | Overweight Maintained | 24 Jan 2025 |
Financial journalist opinion
Based on 11 articles about COR published over the past 30 days
Positive
Zacks Investment Research
1 week ago
Here is Why Growth Investors Should Buy Cencora (COR) Now
Cencora (COR) possesses solid growth attributes, which could help it handily outperform the market.
Positive
Zacks Investment Research
1 week ago
4 GARP Stocks That Investors Can Scoop Up for Maximum Returns
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. NVDA, COR, JBL and KLAC hold promise.
Positive
Investors Business Daily
2 weeks ago
This Medical Services Stock Looks Relatively Healthy In A Sick Market
This medical supplies distributor raised its 2025 earnings outlook on Monday. Cencora stock is near a buy point of a newly formed base.
Positive
Zacks Investment Research
2 weeks ago
Here's Why Cencora (COR) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Positive
Zacks Investment Research
2 weeks ago
Here's Why Cencora (COR) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Positive
Zacks Investment Research
2 weeks ago
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?
Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Positive
Zacks Investment Research
2 weeks ago
Here's Why You Should Add Cencora Stock to Your Portfolio Now
COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
Positive
Zacks Investment Research
2 weeks ago
Why Is Cencora (COR) Up 3.1% Since Last Earnings Report?
Cencora (COR) reported earnings 30 days ago. What's next for the stock?
Positive
Zacks Investment Research
3 weeks ago
Scoop Up These 3 GARP Stocks to Receive Handsome Returns
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. SFM, COR and AXP are some stocks that hold promise.
Positive
Zacks Investment Research
3 weeks ago
3 Reasons Why Growth Investors Shouldn't Overlook Cencora (COR)
Cencora (COR) possesses solid growth attributes, which could help it handily outperform the market.
Charts implemented using Lightweight Charts™